Chronic kidney disease (CKD) affects almost 700 million people worldwide but the awareness about it is less than 10% among patients who already have CKD.

CKD can be easily diagnosed by two simple and inexpensive tests: urianalysis and serum creatinine measurement with subsequent calculation of estimated glomerular filtration rate. However, these two simple tests are not performed in a substantial proportion of high-risk patients (those having diabetes, hypertension, etc). The lack of timely diagnostics leads to the absence of treatment and CKD progression - and that is a huge pitfall because at the early stages, CKD could be treated by affordable medicines like ACEI or ARB (majority of them are available as generics).

Despite this high burden, CKD is not included in health strategies in many countries.

Feel free to use, share and repost these infographics to increase awareness about CKD and call for action:
1. CKD prevalence at global level https://bit.ly/CKDGlobPrev
2. CKD mortality at global level https://bit.ly/CKDGlobMort
3. CKD prevalence in 21 world's regions https://bit.ly/CKDRegPrev
4. CKD mortality in 21 world's regions https://bit.ly/CKDRegMort
5. CKD YLDs, YLLs and DALYs at global level https://bit.ly/CKDGlobDALY

More details on CKD epidemiology are available in the Lancet paper https://www.thelancet.com/article/S0140-6736(20)30045-3/fulltext